Suven Life Sciences Limited (NSE:SUVEN)
India flag India · Delayed Price · Currency is INR
197.00
+19.02 (10.69%)
Apr 10, 2026, 3:30 PM IST

Suven Life Sciences Statistics

Total Valuation

NSE:SUVEN has a market cap or net worth of INR 51.33 billion. The enterprise value is 48.76 billion.

Market Cap51.33B
Enterprise Value 48.76B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 263.72M
Shares Outstanding n/a
Shares Change (YoY) +2.12%
Shares Change (QoQ) +0.83%
Owned by Insiders (%) 1.88%
Owned by Institutions (%) 2.94%
Float 75.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 726.93
PB Ratio 18.25
P/TBV Ratio 18.26
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -17.75
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -1,188.91%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.89%
Revenue Per Employee 511,710
Profits Per Employee -19.91M
Employee Count138
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +65.09% in the last 52 weeks. The beta is 0.30, so NSE:SUVEN's price volatility has been lower than the market average.

Beta (5Y) 0.30
52-Week Price Change +65.09%
50-Day Moving Average 147.18
200-Day Moving Average 193.59
Relative Strength Index (RSI) 79.86
Average Volume (20 Days) 722,957

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:SUVEN had revenue of INR 70.62 million and -2.75 billion in losses. Loss per share was -12.35.

Revenue70.62M
Gross Profit 63.10M
Operating Income -2.83B
Pretax Income -2.75B
Net Income -2.75B
EBITDA -2.78B
EBIT -2.83B
Loss Per Share -12.35
Full Income Statement

Balance Sheet

The company has 2.57 billion in cash and n/a in debt, with a net cash position of 2.57 billion.

Cash & Cash Equivalents 2.57B
Total Debt n/a
Net Cash 2.57B
Net Cash Per Share n/a
Equity (Book Value) 2.81B
Book Value Per Share 12.66
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 48.94M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 89.36%
Operating Margin -4,002.84%
Pretax Margin -3,889.96%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NSE:SUVEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.12%
Shareholder Yield -2.12%
Earnings Yield -5.35%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1